FrancophonIA/ELRC3.0 huggingface dataset:
English: However, overdose with darifenacin can potentially lead to severe anticholinergic effects and should be treated accordingly.
Danish: De mest almindelige bivirkninger var mundtørhed, forstoppelse, hovedpine, dyspepsi og nasal tørhed.Overdosering med darifenacin kan imidlertid potentielt føre til svære antikolinerge virkninger, og skal behandles i overensstemmelse hermed.
English: How to take Emselex
Danish: Sådan skal du tage Emselex
English: NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER Merus Labs Luxco II S.à R.L.
Danish: NAVN OG ADRESSE PÅ INDEHAVEREN AF MARKEDSFØRINGSTILLADELSEN Merus Labs Luxco II S.à R.L.
English: 56 tablets (PVC/PVDC/alu blisters)
Danish: 56 tabletter (PVC/PVDC/ALU blister)
English: • if you are receiving treatment for narrow-angle glaucoma.
Danish: • hvis du er i behandling for højt tryk i øjet (snævervinklet glaukom).
English: 56 tablets (PVC/CTFE/alu blisters)
Danish: 56 tabletter (PVC/CTFE/ALU blister)
English: In patients receiving substances that are potent CYP2D6 inhibitors, such as paroxetine, terbinafine, quinidine and cimetidine, treatment should start with the 7.5 mg dose.
Danish: Til patienter, som får stoffer, der er potente CYP2D6 hæmmere, såsom paroxetin, terbinafin, quinidin og cimetidin, bør behandlingen starte med en dosis på 7,5 mg. Doseringen kan titreres til 15 mg daglig for at opnå forbedret klinisk respons forudsat, at doseringen er vel tolereret.
English: If any of these apply to you, tell your doctor before you take Emselex.
Danish: Kontakt lægen, inden du begynder at tage Emselex, hvis nogen af ovenstående tilstande gælder for dig.
English: 49 tablets (PVC/PVDC/alu blisters)
Danish: 49 tabletter (PVC/PVDC/ALU blister)
English: 49 tablets (PVC/CTFE/alu blisters)
Danish: 49 tabletter (PVC/CTFE/ALU blister)
English: 7 tablets (PVC/PVDC/alu blisters)
Danish: 7 tabletter (PVC/PVDC/ALU blister)
English: 7 tablets (PVC/CTFE/alu blisters)
Danish: 7 tabletter (PVC/CTFE/ALU blister)
English: Possible side effects
Danish: Nogle bivirkninger kan være alvorlige
English: 98 tablets (PVC/PVDC/alu blisters)
Danish: 98 tabletter (PVC/PVDC/ALU blister)
English: 28 tablets (PVC/CTFE/alu blisters)
Danish: 28 tabletter (PVC/CTFE/ALU blister)
English: 98 tablets (PVC/CTFE/alu blisters)
Danish: 98 tabletter (PVC/CTFE/ALU blister)
English: 28 tablets (PVC/PVDC/alu blisters)
Danish: 28 tabletter (PVC/PVDC/ALU blister)
English: 14 tablets (PVC/PVDC/alu blisters)
Danish: 14 tabletter (PVC/PVDC/ALU blister)
English: MARKETING AUTHORISATION NUMBER(S) EU/1/04/294/013
Danish: MARKEDSFØRINGSTILLADELSESNUMMER (NUMRE) EU/1/04/294/013
English: MARKETING AUTHORISATION NUMBER(S) EU/1/04/294/007
Danish: MARKEDSFØRINGSTILLADELSESNUMMER (NUMRE) EU/1/04/294/007
English: In patients receiving substances that are moderate CYP3A4 inhibitors, such as fluconazole, grapefruit juice and erythromycin, the recommended starting dose is 7.5 mg daily.
Danish: Til patienter, som får stoffer, der er moderate CYP3A4 hæmmere, såsom fluconazol, grapefrugtjuice og erythromycin bør behandlingen starte med en dosis på 7,5 mg. Doseringen kan titreres til 15 mg daglig for at opnå forbedret klinisk respons forudsat, at doseringen er vel tolereret.
English: 14 tablets (PVC/CTFE/alu blisters)
Danish: 14 tabletter (PVC/CTFE/ALU blister)
English: Dizziness, dysgeusia, somnolence
Danish: Svimmelhed, smagsforstyrrelser, somnolens
English: MARKETING AUTHORISATION NUMBER(S) EU/1/04/294/001
Danish: MARKEDSFØRINGSTILLADELSESNUMMER (NUMRE) EU/1/04/294/001
English: A. MANUFACTURER RESPONSIBLE FOR BATCH RELEASE Name and address of the manufacturer responsible for batch release Merus Labs Netherlands B.V.,
Danish: Navn og adresse på fremstilleren ansvarlig for batchfrigivelse
English: MARKETING AUTHORISATION NUMBER(S) EU/1/04/294/014
Danish: MARKEDSFØRINGSTILLADELSESNUMMER (NUMRE) EU/1/04/294/014
English: MARKETING AUTHORISATION HOLDER Merus Labs Luxco II S.à R.L.
Danish: Indehaver af markedsføringstilladelsen Merus Labs Luxco II S.à R.L.
English: NAME OF THE MARKETING AUTHORISATION HOLDER Merus Labs Luxco II S.à R.L.
Danish: NAVN PÅ INDEHAVEREN AF MARKEDSFØRINGSTILLADELSEN Merus Labs Luxco II S.à R.L.
English: Erectile dysfunction, vaginitis General disorders and administration site conditions Uncommon
Danish: Erektil dysfunktion, vaginit
English: MARKETING AUTHORISATION NUMBER(S) EU/1/04/294/001-006
Danish: MARKEDSFØRINGSTILLADELSESNUMMER (NUMRE) EU/1/04/294/007-012
English: The European Commission granted a marketing authorisation valid throughout the European Union, for Purevax RCP FeLV on 23 February 2005.
Danish: Europa-Kommissionen udstedte en markedsføringstilladelse med gyldighed i hele Den Europæiske Union for Purevax RCP FeLV den 23. februar 2005.
English: The CVMP concluded that the benefits of Purevax RCP FeLV exceed the risks for the active immunisation of cats aged eight weeks or older against the diseases listed above approved indicationsand recommended that Purevax RCP FeLV be given a marketing authorisation.
Danish: CVMP konkluderede, at fordelene ved Purevax RCP FeLV overstiger risiciene ved aktiv immunisering af katte i alderen otte uger eller ældre mod de sygdomme, der er anført under ovennævnte godkendte indikationer, og anbefalede, at Purevax RCP FeLV tildeles markedsføringstilladelse.
English: The cat should be revaccinated for all components one year after the first vaccination course, then every year for feline leukaemia, and every three years for rhinotracheitis, calicivirosis and panleucopenia.
Danish: Katten bør revaccineres for alle komponenter ét år efter det første vaccinationsforløb, derefter hvert år for felin leukæmi, og hvert tredje år for rhinotracheitis, calicivirose og panleukopeni.
English: The benefit-risk balance may be found in the scientific discussion 6 of this EPAR.
Danish: Afvejningen af fordele og risici (benefit/risk-forholdet) fremgår af afsnit 6 om den videnskabelige drøftelse i denne EPAR.
English: When a cat is given the vaccine, the immune system recognises the weakened or killed viruses and the FeLV proteins as ‘foreign' and makes antibodies against them.
Danish: Når en kat får vaccinen, opfatter immunsystemet de svækkede eller dræbte virus og FeLV-proteinerne som "fremmede" og danner antistoffer mod dem.
English: In the field the studies of Purevax RCP FeLV looked at the basic vaccination schedule (2 injections 3-4 weeks apart) and at the booster vaccination.
Danish: Feltundersøgelserne af Purevax RCP FeLV vedrørte basisvaccinationsplanen (2 injektioner med 3-4 ugers mellemrum) og boostervaccinationen.
English: To protect against feline leukaemia the vaccine contains two genes from the FeLV called env and gag, which have been inserted into another vector (carrier) virus called canarypox using ‘recombinant DNA technology'.
Danish: For at beskytte mod felin leukæmi indeholder vaccinen to gener fra FeLV, env og gag, som er indsat i et andet vektor- eller bærevirus, canarypox, ved hjælp af "rekombinant DNA-teknologi".
English: The effectiveness of Purevax RCP FeLV has been studied in several trials in laboratory conditions where cats were vaccinated and infected with herpesvirus, calicivirus, parvovirus or leukaemia virus.
Danish: Effektiviteten af Purevax RCP FeLV er undersøgt under laboratorieforhold i flere undersøgelser, hvor kattene blev vaccineret og inficeret med herpesvirus, calicivirus, parvovirus eller leukæmivirus.
English: Purevax RCP FeLV should not be used in pregnant cats.
Danish: Purevax RCP FeLV bør ikke anvendes hos drægtige katte.
English: Purevax RCP FeLV is used to vaccinate cats from the age of 8 weeks against:
Danish: Purevax RCP FeLV anvendes til at vaccinere katte fra 8-ugers alderen mod:
English: Purevax RCP FeLV is a vaccine.
Danish: Purevax RCP FeLV er en vaccine.
English: Purevax RCP FeLV is available as a lyophilisate (freeze-dried pellet) and solvent that are made up into a suspension for injection.
Danish: Purevax RCP FeLV leveres som et lyofilisat (en frysetørret pellet) med opløsningsvæske (solvens), der benyttes til at fremstille en suspension til indsprøjtning.
English: Purevax RCP FeLV is a veterinary vaccine that contains:
Danish: Purevax RCP FeLV er en veterinær vaccine, der indeholder:
English: Purevax RCP FeLV contains small amounts of weakened or killed viruses that cause feline viral rhinotracheitis, calicivirosis and panleucopenia.
Danish: Purevax RCP FeLV indeholder små mængder svækkede eller dræbte virus, der forårsager felin viral rhinotracheitis, calicivirose og panleukopeni.
English: In laboratory conditions Purevax RCP FeLV was demonstrated to provide protection against the diseases listed above.
Danish: Purevax RCP FeLV er påvist at beskytte mod ovennævnte sygdomme under laboratoriebetingelser.
English: For a full list of the side-effects reported with Purevax RCP FeLV, see the package leaflet.
Danish: Den fuldstændige liste over indberettede bivirkninger med Purevax RCP FeLV fremgår af indlægssedlen.
English: Feline viral rhinotracheitis, feline panleucopenia (live attenuated), feline leukaemia and feline calicivirosis (inactivated) vaccine
Danish: Felin viral rhinotracheitis-, felin panleukopeni- (levende, svækket), felin leukæmi- og felin calicivirose- (inaktiveret) vaccine
English: Other information about Purevax RCP FeLV:
Danish: Andre oplysninger om Purevax RCP FeLV:
English: In the study looking at booster vaccination, antibody levels against rhinotracheitis herpesvirus, calicivirus infection and feline panleucopenia remained stable at a high level or increased slightly.
Danish: I undersøgelsen vedrørende boostervaccination holdt indholdet af antistoffer mod infektion med rhinotracheitis herpesvirus, calicivirus-infektion og felin panleukopenivirus sig stabilt på et højt niveau eller steg en smule.
English: The main measure of effectiveness was the level of antibodies in the blood against the viruses in the vaccine, with the exception of the FeLV component, whose effectiveness in preventing infection had already been demonstrated in other studies.
Danish: FeLV-komponenten, hvis effektivitet til forebyggelse af infektion allerede var påvist i andre undersøgelser.
English: What is the risk associated with Purevax RCP FeLV?
Danish: Hvilken risiko er der forbundet med Purevax RCP FeLV?
English: Why has Purevax RCP FeLV been approved?
Danish: Hvorfor blev Purevax RCP FeLV godkendt?
English: What is Purevax RCP FeLV?
Danish: Hvad er Purevax RCP FeLV?
English: How has Purevax RCP FeLV been studied?
Danish: Hvordan blev Purevax RCP FeLV undersøgt?
English: What is Purevax RCP FeLV used for?
Danish: Hvad anvendes Purevax RCP FeLV til?
English: How does Purevax RCP FeLV work?
Danish: Hvordan virker Purevax RCP FeLV?
English: What benefit has Purevax RCP FeLV shown during the studies?
Danish: Hvilken fordel viser undersøgelserne, at der er ved Purevax RCP FeLV?
English: This is because the indications for these medicines have been restricted.
Danish: Dette skyldes, at indikationerne for disse lægemidler er blevet indskrænket.
English: 11 March 2019 EMA/175398/2019
Danish: 11. marts 2019 EMA/175398/2019
English: The review concerned only medicines given systemically (by mouth or injection) and inhaled medicines.
Danish: Gennemgangen omfattede kun systemiske lægemidler (der indgives gennem munden eller ved injektion) og inhalerede lægemidler.
English: The review of fluoroquinolones and quinolones was initiated on 9 February 2017 at the request of the German medicines authority (BfArM), under Article 31 of Directive 2001/83/EC.
Danish: Gennemgangen af fluoroquinoloner og quinoloner blev indledt den 9. februar 2017 på anmodning af den tyske lægemiddelstyrelse (BfArM) i overensstemmelse med artikel 31 i direktiv 2001/83/EF.
English: You and your doctor will decide if you can continue treatment or if you need to take another type of antibiotic.
Danish: Lægen vil drøfte med dig, om du kan fortsætte behandlingen, eller om du skal have en anden type antibiotikum.
English: The review was first carried out by the Pharmacovigilance Risk Assessment Committee (PRAC), the Committee responsible for the evaluation of safety issues for human medicines.
Danish: Gennemgangen blev først foretaget af Udvalget for Risikovurdering inden for Lægemiddelovervågning (PRAC), der har ansvar for at vurdere sikkerhedsspørgsmål vedrørende lægemidler til mennesker.
English: Restrictions on the use of fluoroquinolone antibiotics will mean that they should not be used:
Danish: En begrænsning af anvendelsen af fluoroquinolon-antibiotika vil betyde, at de ikke bør anvendes:
English: Since the use of a corticosteroid with a fluoroquinolone also increases this risk, combined use of these medicines should be avoided.
Danish: Da anvendelse af et kortikosteroid sammen med et fluoroquinolon også øger denne risiko, bør kombineret brug af disse lægemidler undgås.
English: The CHMP confirmed that the use of the remaining fluoroquinolone antibiotics should be restricted.
Danish: CHMP bekræftede, at anvendelsen af de tilbageværende fluoroquinolon-antibiotika bør indskrænkes.
English: National authorities will enforce this decision for the fluoroquinolone and quinolone medicines authorised in their countries and they will also take other appropriate measures to promote the correct use of these antibiotics.
Danish: De nationale myndigheder vil håndhæve denne afgørelse vedrørende fluoroquinolon- og quinolonlægemidler, der er godkendt i de pågældende lande, og de vil også træffe andre relevante foranstaltninger for at sikre korrekt anvendelse af disse antibiotika.
English: The final PRAC recommendations were adopted on 4 October 2018 and then sent to the Committee for Medicinal Products for Human Use (CHMP), responsible for questions concerning medicines for human use, which adopted the Agency's opinion.
Danish: De endelige anbefalinger fra PRAC blev vedtaget den 4. oktober 2018 og derefter fremsendt til Udvalget for Lægemidler til Mennesker (CHMP), som har ansvar for alle spørgsmål vedrørende lægemidler til mennesker, og som vedtog agenturets udtalelse.
English: • Speak with your doctor if you are taking a corticosteroid (medicines such as hydrocortisone and prednisolone) or need to have treatment with a corticosteroid.
Danish: • Tal med lægen, hvis du tager et kortikosteroid (f.eks. hydrokortison og prednisolon), eller hvis du får brug for behandling med et kortikosteroid.
English: EMA's human medicines committee (CHMP) endorsed the recommendations of EMA's safety committee (PRAC) and concluded that the marketing authorisation of medicines containing cinoxacin, flumequine, nalidixic acid, and pipemidic acid should be suspended.
Danish: EMA's Udvalg for Lægemidler til Mennesker (CHMP) bifaldt anbefalingerne fra EMA's sikkerhedskomité (PRAC) og vurderede, at markedsføringstilladelsen for lægemidler, der indeholder cinoxacin, flumequin, nalidixinsyre og pipemidinsyre, bør suspenderes.
English: Fluoroquinolones are of value in certain infections, including some life-threatening ones, where alternative antibiotics are not sufficiently effective.
Danish: Fluoroquinoloner er værdifulde ved visse infektioner, herunder en række livstruende infektioner, hvor andre antibiotika ikke er tilstrækkeligt effektive.
English: • to treat mild or moderate bacterial infections unless other antibacterial medicines commonly recommended for these infections cannot be used.
Danish: • til behandling af milde til moderate bakterieinfektioner, medmindre andre lægemidler, der normalt anbefales til behandling af bakterieinfektioner, ikke kan anvendes.
English: • The benefits and risks of fluoroquinolones will be monitored continuously and a drug utilisation study will evaluate the effectiveness of the new measures to reduce inappropriate use of fluoroquinolones by investigating changes in prescribing behaviour.
Danish: • Fordelene og risiciene ved fluoroquinoloner vil blive løbende overvåget, og i en undersøgelse af lægemiddelanvendelse vil det blive vurderet, hvor effektive de nye foranstaltninger er til at mindske uhensigtsmæssig brug af fluoroquinoloner ved at se nærmere på ændringerne i ordinationsadfærden.
English: They should be used with special caution in the elderly, patients with kidney disease and those who have had an organ transplantation because these patients are at a higher risk of tendon injury.
Danish: De bør anvendes med særlig forsigtighed hos ældre patienter, patienter med nyresygdom og patienter, der har fået foretaget organtransplantation, da disse patienter har højere risiko for seneskade.
English: Concomitant treatment with a fluoroquinolone and a corticosteroid should be avoided.
Danish: Samtidig behandling med et fluoroquinolon og et kortikosteroid bør undgås.
English: • to treat non-bacterial infections, e.g. non-bacterial (chronic) prostatitis;
Danish: • til behandling af ikke-bakterielle infektioner, f.eks. ikke-bakteriel (kronisk) prostatitis
English: Fluoroquinolones and quinolones are a class of broad-spectrum antibiotics that are active against bacteria of both Gram-negative and Gram-positive classes.
Danish: Fluoroquinoloner og quinoloner er en klasse af bredspektrede antibiotika, der er virksomme mod både gramnegative og grampositive bakterier.
English: The review incorporated the views of patients, healthcare professionals and academics presented at EMA's public hearing on fluoroquinolone and quinolone antibiotics in June 2018.
Danish: Ved gennemgangen tog EMA hensyn til de synspunkter fra patienter, sundhedspersoner og forskere, der blev fremsat ved EMA's offentlige høring om fluoroquinolon- og quinolon-antibiotika i juni 2018.
English: • to treat infections that might get better without treatment or are not severe (such as throat infections);
Danish: • til behandling af infektioner, der kan gå over af sig selv uden behandling, eller som ikke er svære (f.eks. halsbetændelse)
English: • Fluoroquinolones are associated with prolonged (up to months or years), serious, disabling and potentially irreversible drug reactions affecting several, sometimes multiple, systems, organ classes and senses.
Danish: • Fluoroquinoloner kan være forbundet med langvarige (op til måneder eller år), alvorlige, invaliderende og potentielt irreversible bivirkninger, der kan indvirke på flere systemer, organklasser og sanser.
English: You may be especially prone to tendon damage if you are taking a corticosteroid and a fluoroquinolone medicine at the same time.
Danish: Du kan være ekstra tilbøjelig til at få seneskade, hvis du tager et kortikosteroid og et fluoroquinolon-lægemiddel samtidigt.
English: • Up-to-date summary of product characteristics should be consulted for authorised indications when considering treatment with a fluoroquinolone medicine.
Danish: • Et ajourført produktresumé bør konsulteres for at tjekke de godkendte indikationer, når det overvejes at iværksætte behandling med et fluoroquinolon-lægemiddel.
English: • You may be more prone to joint pain or swelling or tendon damage if you are aged over 60 years, your kidneys do not work well or you have received organ transplantation.
Danish: • Du kan være mere tilbøjelig til at opleve ledsmerter/ledhævelse eller seneskade, hvis du er over 60 år, hvis du har nedsat nyrefunktion, eller hvis du har fået en organtransplantation.
English: • Stop taking a fluoroquinolone medicine and contact your doctor at once in the following cases:
Danish: • Du skal stoppe med at tage fluoroquinolon-medicin og kontakte lægen med det samme:
English: The review covered medicines containing the following fluoroquinolone and quinolone antibiotics: cinoxacin, ciprofloxacin, flumequine, levofloxacin, lomefloxacin, moxifloxacin, nalidixic acid, norfloxacin, ofloxacin, pefloxacin, pipemidic acid, prulifloxacin and rufloxacin.
Danish: Gennemgangen omfattede lægemidler, der indeholder følgende fluoroquinolon- og quinolonantibiotika: cinoxacin, ciprofloxacin, flumequin, levofloxacin, lomefloxacin, moxifloxacin, nalidixinsyre, norfloxacin, ofloxacin, pefloxacin, pipemidinsyre, prulifloxacin og rufloxacin.
English: • Patients who are older, have renal impairment or have had solid organ transplantation and those being treated with a corticosteroid are at higher risk of tendon damage.
Danish: • Ældre patienter, patienter med nedsat nyrefunktion, patienter, der har fået transplanteret et solidt organ, og patienter, der er i behandling med et kortikosteroid, har større risiko for at opleve seneskade.
English: On 15 November 2018, EMA finalised a review of serious, disabling and potentially permanent side effects with quinolone and fluoroquinolone antibiotics given by mouth, injection or inhalation.
Danish: Den 15. november 2018 afsluttede EMA en gennemgang af alvorlige, invaliderende og potentielt permanente bivirkninger ved quinolon- og fluoroquinolon-antibiotika indgivet gennem munden, ved injektion eller ved inhalation.
English: o at the first sign of tendon injury, such as tendon pain or swelling - rest the painful area;
Danish: o ved det første tegn på seneskade, f.eks. smerter eller hævelse i en sene (sørg for at hvile det smertefulde område)
English: • Tendon swelling and injury may occur within 2 days of starting treatment with a fluoroquinolone but may even occur several months after stopping treatment.
Danish: • Hævede sener eller seneskade kan opstå inden for 2 dage efter påbegyndelse af behandling med et fluoroquinolon, men kan også opstå flere måneder efter endt behandling.
English: In addition, the prescribing information for healthcare professionals and information for patients will describe the disabling and potentially permanent side effects and advise patients to stop treatment with a fluoroquinolone antibiotic at the first sign of a side effect involving muscles, tendons or joints and the nervous system.
Danish: Derudover vil ordinationsoplysningerne til sundhedspersoner og informationen til patienter omfatte en beskrivelse af de invaliderende og potentielt permanente bivirkninger og gøre patienterne opmærksomme på, at de skal stoppe behandling med et fluoroquinolon-antibiotikum ved første tegn på en bivirkning i muskler, sener, led eller nervesystem.
English: • Fluoroquinolone treatment should be discontinued at the first sign of tendon pain or inflammation and patients should be advised to stop treatment with a fluoroquinolone and speak with the doctor in case of symptoms of neuropathy such as pain, burning, tingling, numbness or weakness so as to prevent development of potentially irreversible condition.
Danish: • Fluoroquinolon-behandling bør seponeres ved første tegn på senesmerter eller -inflammation, og patienterne skal have at vide, at de skal ophøre med fluoroquinolon-behandlingen og tale med lægen, hvis de oplever symptomer på neuropati som f.eks. smerter, brændende fornemmelse, snurren, følelsesløshed eller svaghed, så det kan undgås, at de udvikler potentielt irreversible tilstande.
English: • If you have any questions or concerns about your medicines, speak to your doctor or pharmacist.
Danish: • Tal med lægen eller apotekspersonalet, hvis du har spørgsmål eller betænkeligheder vedrørende din medicin.
English: • Tendon damage (especially to Achilles tendon but also other tendons) can occur within 48 hours of starting fluoroquinolone treatment but the damage may be delayed several months after stopping treatment.
Danish: • Seneskade (navnlig skade på akillessenen, men også andre sener) kan opstå inden for 48 timer efter påbegyndelse af behandling med et fluoroquinolon-lægemiddel; der kan også opstå seneskade flere måneder efter ophør med behandlingen.
English: • for preventing traveller's diarrhoea or recurring lower urinary tract infections (urine infections that do not extend beyond the bladder);
Danish: • til behandling af rejsediarré eller tilbagevendende nedre urinvejsinfektion (blærebetændelse)
English: • Fluoroquinolone medicines (which contain ciprofloxacin, levofloxacin, lomefloxacin, moxifloxacin, norfloxacin, ofloxacin, pefloxacin, prulifloxacin and rufloxacin) can cause long-lasting, disabling and potentially permanent side effects involving tendons, muscles, joints and the nervous system.
Danish: • Fluoroquinolon-lægemidler (der indeholder ciprofloxacin, levofloxacin, lomefloxacin, moxifloxacin, norfloxacin, ofloxacin, pefloxacin, prulifloxacin og rufloxacin) kan forårsage længerevarende, invaliderende og potentielt permanente bivirkninger i sener, muskler, led og nervesystem.